by Gemma Escarré,
Consultancy Eignapharma, member of CataloniaBio & HealthTech, has reached a collaboration agreement with Biogem, an Italian consortium specialised in lab scale development and production of biosimilars, monoclonal antibodies, new biological entities and related preclinical studies.
Under this agreement Eignapharma will use its commercial efforts to put at the industry disposal Biogem’s research and development capabilities consisting on documented small-scale processes and fully protocolised technology transfers procedures to allow a safe scaleup to industrial production.
Biogem is conformed by the Italian National Research Council (CNR),
the Area Science Park of Trieste, the University of Naples "Federico II", the University of Milano Bicocca, the University Lumsa of Rome, among others.
Eignapharma, based in Barcelona, provides services in the fields of regulatory affairs, pharmacovigilance and quality systems in Europe.
Photo: Eignapharma team in the latest CataloniaBio & HealthTech gala dinner.